ICD-10 Coding for Cervical Intraepithelial Neoplasia III(D06.0, D06.9, D06.9B)
Explore the ICD-10 coding for cervical intraepithelial neoplasia III (CIN III), including documentation requirements and clinical validation criteria.
Complete code families applicable to Cervical Intraepithelial Neoplasia III
Key Information
Essential facts and insights aboutCervical Intraepithelial Neoplasia III
Alternative codes to consider when ruling out similar conditions
Use for CIN II, not CIN III.
Documentation & Coding Risks
Avoid these common issues when documenting Cervical Intraepithelial Neoplasia III.
Documenting 'high-grade lesion' without specifying CIN III
Impact
Clinical: May lead to inappropriate treatment planning., Regulatory: Non-compliance with documentation standards., Financial: Potential claim denials due to lack of specificity.
Mitigation
Use specific CIN terminology., Verify histological findings.
Coding CIN 2-3 as D06._ without confirmation
Impact
Reimbursement: Incorrect coding may lead to claim denials., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate clinical data reporting.
Mitigation
Ensure p16 positivity and explicit CIN III confirmation before coding.
Histological Confirmation
Impact
Coding CIN III without histological confirmation.
Mitigation
Require biopsy and p16 results before coding.